Primary central nervous system lymphoma epidemiology and demographics

Revision as of 16:46, 18 February 2016 by Sujit Routray (talk | contribs)
Jump to navigation Jump to search

Primary central nervous system lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary Central Nervous System Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary central nervous system lymphoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary central nervous system lymphoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary central nervous system lymphoma epidemiology and demographics

CDC on Primary central nervous system lymphoma epidemiology and demographics

Primary central nervous system lymphoma epidemiology and demographics in the news

Blogs on Primary central nervous system lymphoma epidemiology and demographics

Directions to Hospitals Treating Primary central nervous system lymphoma

Risk calculators and risk factors for Primary central nervous system lymphoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Epidemiology and Demographics

Prevalence

  • Primary central nervous system lymphoma constitutes approximately 3%-4% of all primary brain tumors.[1]
  • Primary CNS lymphoma constitues approximately 1%-2% of all lymphomas.[1]

Incidence

  • The overall incidence rate of primary central nervous system lymphoma is 0.4 cases per 100,000 individuals per year.[1]

The incidence of PCNSL in the immunocompetent population has been reported to have increased more than 10-fold from 2.5 cases to 30 cases per 10 million population[2][3]. The cause for the increase in incidence of this disease in the immunocompetent population is unknown.

Age

Primary central nervous system lymphoma does not have predilections for any age group. In the immunocompetent population, PCNSL typically affects older patients in their 50's and 60's.

References

  1. 1.0 1.1 1.2 Manenti, G.; Di Giuliano, F.; Bindi, A.; Liberto, V.; Funel, V.; Garaci, F. G.; Floris, R.; Simonetti, G. (2013). "A Case of Primary T-Cell Central Nervous System Lymphoma: MR Imaging and MR Spectroscopy Assessment". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/916348. ISSN 2090-6862.
  2. Eby NL, Grufferman S, Flannelly CM, Schold SC, Jr., Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer 1988;62(11):2461-2465
  3. Corn BW, Marcus SM, Topham A, Hauck W, Curran WJ, Jr. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 1997;79(12):2409-2413


Template:WikiDoc Sources